Vanguard Asset Management
PLSE icon

Vanguard Asset Management’s Pulse Biosciences PLSE Stock Holding History

Vanguard Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
11,602
– – ﹤0.01% 2323
2026
Q1 		$250K Buy
+11,602
New +$214K ﹤0.01% 2327

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Asset Management's PLSE Position: Q2 2026 in Review

Vanguard Asset Management held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 11,602 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Vanguard Asset Management first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Vanguard Asset Management held 11,602 shares of Pulse Biosciences worth $322K as of Q2 2026.
  • Vanguard Asset Management left its Pulse Biosciences share count unchanged in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #2323 holding.
  • Vanguard Asset Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.